Analysis of gene expression in stage I serous tumors identifies critical pathways altered in ovarian cancer

Jeremy Chien, Jian Bing Fan, Debra A. Bell, Craig April, Brandy Klotzle, Takayo Ota, Wilma L. Lingle, Jesus Gonzalez Bosquet, Viji Shridhar, Lynn C. Hartmann

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Objective: Despite recent advances in the conceptual understanding of the pathogenesis of ovarian cancer, it remains the foremost cause of death from gynecologic malignancies in developed countries. The main reason for such a high rate of mortality is the lack of sensitive and specific biomarkers and imaging techniques for early detection of ovarian cancer. Additional biological insights into early-stage ovarian carcinogenesis are needed to help speed the development of markers for early detection of ovarian cancer. The objective of this study was to characterize differentially expressed genes in high-grade stage I serous carcinoma of the ovary. Methods: We analyzed gene expression in macrodissected formalin-fixed, paraffin-embedded samples from 5 high-grade stage I serous carcinomas and 5 stage I borderline tumors of the ovary using the Illumina Whole Genome DASL assay (cDNA-mediated annealing, selection, extension, and ligation) corresponding to 24,000 genes. Significance Analysis of Microarrays was performed to determine differentially expressed genes in stage I serous carcinoma, and class prediction analysis was performed to determine the predictive value of differentially expressed gene sets to correctly classify serous carcinoma from borderline tumors in 3 independent data sets. Altered transcription factor pathways and biological pathways unique to stage I serous carcinoma were identified through class comparison of differentially expressed genes. Results: Unsupervised cluster analysis of gene expression correctly classified stage I serous carcinomas from serous borderline tumors. Supervised analysis identified several known, as well as novel, genes differentially expressed in stage I ovarian cancer. Using a differentially expressed gene set, class comparison prediction analysis correctly identified serous carcinomas from serous borderline tumors in 3 independent data sets at over 80% accuracy, sensitivity, and specificity. Pathway analysis demonstrated the significance of p53 and E2F pathways in serous carcinogenesis and significant involvements of cell cycle and immune response pathways in stage I serous epithelial ovarian cancer. Conclusion: We have identified differentially expressed genes associated with the carcinogenesis of high-grade stage I serous EOC. Furthermore, integrative analysis of biological and transcription pathway data contributed to the confirmation of important biological pathways and discovery of additional unique genes and pathways that may have potential importance in ovarian pathogenesis and biomarker development.

Original languageEnglish (US)
Pages (from-to)3-11
Number of pages9
JournalGynecologic Oncology
Volume114
Issue number1
DOIs
StatePublished - Jul 1 2009
Externally publishedYes

Fingerprint

Critical Pathways
Ovarian Neoplasms
Gene Expression
Carcinoma
Genes
Neoplasms
Carcinogenesis
Early Detection of Cancer
Ovary
Biomarkers
Microarray Analysis
Developed Countries
Paraffin
Formaldehyde
Ligation
Cluster Analysis
Cause of Death
Cell Cycle
Transcription Factors
Complementary DNA

Keywords

  • E2F
  • Gene expression
  • p53
  • Serous borderline tumor
  • Stage I serous carcinoma

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynecology

Cite this

Analysis of gene expression in stage I serous tumors identifies critical pathways altered in ovarian cancer. / Chien, Jeremy; Fan, Jian Bing; Bell, Debra A.; April, Craig; Klotzle, Brandy; Ota, Takayo; Lingle, Wilma L.; Gonzalez Bosquet, Jesus; Shridhar, Viji; Hartmann, Lynn C.

In: Gynecologic Oncology, Vol. 114, No. 1, 01.07.2009, p. 3-11.

Research output: Contribution to journalArticle

Chien, J, Fan, JB, Bell, DA, April, C, Klotzle, B, Ota, T, Lingle, WL, Gonzalez Bosquet, J, Shridhar, V & Hartmann, LC 2009, 'Analysis of gene expression in stage I serous tumors identifies critical pathways altered in ovarian cancer', Gynecologic Oncology, vol. 114, no. 1, pp. 3-11. https://doi.org/10.1016/j.ygyno.2009.04.002
Chien, Jeremy ; Fan, Jian Bing ; Bell, Debra A. ; April, Craig ; Klotzle, Brandy ; Ota, Takayo ; Lingle, Wilma L. ; Gonzalez Bosquet, Jesus ; Shridhar, Viji ; Hartmann, Lynn C. / Analysis of gene expression in stage I serous tumors identifies critical pathways altered in ovarian cancer. In: Gynecologic Oncology. 2009 ; Vol. 114, No. 1. pp. 3-11.
@article{418b04beda0c4f78be95f8454a9c2582,
title = "Analysis of gene expression in stage I serous tumors identifies critical pathways altered in ovarian cancer",
abstract = "Objective: Despite recent advances in the conceptual understanding of the pathogenesis of ovarian cancer, it remains the foremost cause of death from gynecologic malignancies in developed countries. The main reason for such a high rate of mortality is the lack of sensitive and specific biomarkers and imaging techniques for early detection of ovarian cancer. Additional biological insights into early-stage ovarian carcinogenesis are needed to help speed the development of markers for early detection of ovarian cancer. The objective of this study was to characterize differentially expressed genes in high-grade stage I serous carcinoma of the ovary. Methods: We analyzed gene expression in macrodissected formalin-fixed, paraffin-embedded samples from 5 high-grade stage I serous carcinomas and 5 stage I borderline tumors of the ovary using the Illumina Whole Genome DASL assay (cDNA-mediated annealing, selection, extension, and ligation) corresponding to 24,000 genes. Significance Analysis of Microarrays was performed to determine differentially expressed genes in stage I serous carcinoma, and class prediction analysis was performed to determine the predictive value of differentially expressed gene sets to correctly classify serous carcinoma from borderline tumors in 3 independent data sets. Altered transcription factor pathways and biological pathways unique to stage I serous carcinoma were identified through class comparison of differentially expressed genes. Results: Unsupervised cluster analysis of gene expression correctly classified stage I serous carcinomas from serous borderline tumors. Supervised analysis identified several known, as well as novel, genes differentially expressed in stage I ovarian cancer. Using a differentially expressed gene set, class comparison prediction analysis correctly identified serous carcinomas from serous borderline tumors in 3 independent data sets at over 80{\%} accuracy, sensitivity, and specificity. Pathway analysis demonstrated the significance of p53 and E2F pathways in serous carcinogenesis and significant involvements of cell cycle and immune response pathways in stage I serous epithelial ovarian cancer. Conclusion: We have identified differentially expressed genes associated with the carcinogenesis of high-grade stage I serous EOC. Furthermore, integrative analysis of biological and transcription pathway data contributed to the confirmation of important biological pathways and discovery of additional unique genes and pathways that may have potential importance in ovarian pathogenesis and biomarker development.",
keywords = "E2F, Gene expression, p53, Serous borderline tumor, Stage I serous carcinoma",
author = "Jeremy Chien and Fan, {Jian Bing} and Bell, {Debra A.} and Craig April and Brandy Klotzle and Takayo Ota and Lingle, {Wilma L.} and {Gonzalez Bosquet}, Jesus and Viji Shridhar and Hartmann, {Lynn C.}",
year = "2009",
month = "7",
day = "1",
doi = "10.1016/j.ygyno.2009.04.002",
language = "English (US)",
volume = "114",
pages = "3--11",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Analysis of gene expression in stage I serous tumors identifies critical pathways altered in ovarian cancer

AU - Chien, Jeremy

AU - Fan, Jian Bing

AU - Bell, Debra A.

AU - April, Craig

AU - Klotzle, Brandy

AU - Ota, Takayo

AU - Lingle, Wilma L.

AU - Gonzalez Bosquet, Jesus

AU - Shridhar, Viji

AU - Hartmann, Lynn C.

PY - 2009/7/1

Y1 - 2009/7/1

N2 - Objective: Despite recent advances in the conceptual understanding of the pathogenesis of ovarian cancer, it remains the foremost cause of death from gynecologic malignancies in developed countries. The main reason for such a high rate of mortality is the lack of sensitive and specific biomarkers and imaging techniques for early detection of ovarian cancer. Additional biological insights into early-stage ovarian carcinogenesis are needed to help speed the development of markers for early detection of ovarian cancer. The objective of this study was to characterize differentially expressed genes in high-grade stage I serous carcinoma of the ovary. Methods: We analyzed gene expression in macrodissected formalin-fixed, paraffin-embedded samples from 5 high-grade stage I serous carcinomas and 5 stage I borderline tumors of the ovary using the Illumina Whole Genome DASL assay (cDNA-mediated annealing, selection, extension, and ligation) corresponding to 24,000 genes. Significance Analysis of Microarrays was performed to determine differentially expressed genes in stage I serous carcinoma, and class prediction analysis was performed to determine the predictive value of differentially expressed gene sets to correctly classify serous carcinoma from borderline tumors in 3 independent data sets. Altered transcription factor pathways and biological pathways unique to stage I serous carcinoma were identified through class comparison of differentially expressed genes. Results: Unsupervised cluster analysis of gene expression correctly classified stage I serous carcinomas from serous borderline tumors. Supervised analysis identified several known, as well as novel, genes differentially expressed in stage I ovarian cancer. Using a differentially expressed gene set, class comparison prediction analysis correctly identified serous carcinomas from serous borderline tumors in 3 independent data sets at over 80% accuracy, sensitivity, and specificity. Pathway analysis demonstrated the significance of p53 and E2F pathways in serous carcinogenesis and significant involvements of cell cycle and immune response pathways in stage I serous epithelial ovarian cancer. Conclusion: We have identified differentially expressed genes associated with the carcinogenesis of high-grade stage I serous EOC. Furthermore, integrative analysis of biological and transcription pathway data contributed to the confirmation of important biological pathways and discovery of additional unique genes and pathways that may have potential importance in ovarian pathogenesis and biomarker development.

AB - Objective: Despite recent advances in the conceptual understanding of the pathogenesis of ovarian cancer, it remains the foremost cause of death from gynecologic malignancies in developed countries. The main reason for such a high rate of mortality is the lack of sensitive and specific biomarkers and imaging techniques for early detection of ovarian cancer. Additional biological insights into early-stage ovarian carcinogenesis are needed to help speed the development of markers for early detection of ovarian cancer. The objective of this study was to characterize differentially expressed genes in high-grade stage I serous carcinoma of the ovary. Methods: We analyzed gene expression in macrodissected formalin-fixed, paraffin-embedded samples from 5 high-grade stage I serous carcinomas and 5 stage I borderline tumors of the ovary using the Illumina Whole Genome DASL assay (cDNA-mediated annealing, selection, extension, and ligation) corresponding to 24,000 genes. Significance Analysis of Microarrays was performed to determine differentially expressed genes in stage I serous carcinoma, and class prediction analysis was performed to determine the predictive value of differentially expressed gene sets to correctly classify serous carcinoma from borderline tumors in 3 independent data sets. Altered transcription factor pathways and biological pathways unique to stage I serous carcinoma were identified through class comparison of differentially expressed genes. Results: Unsupervised cluster analysis of gene expression correctly classified stage I serous carcinomas from serous borderline tumors. Supervised analysis identified several known, as well as novel, genes differentially expressed in stage I ovarian cancer. Using a differentially expressed gene set, class comparison prediction analysis correctly identified serous carcinomas from serous borderline tumors in 3 independent data sets at over 80% accuracy, sensitivity, and specificity. Pathway analysis demonstrated the significance of p53 and E2F pathways in serous carcinogenesis and significant involvements of cell cycle and immune response pathways in stage I serous epithelial ovarian cancer. Conclusion: We have identified differentially expressed genes associated with the carcinogenesis of high-grade stage I serous EOC. Furthermore, integrative analysis of biological and transcription pathway data contributed to the confirmation of important biological pathways and discovery of additional unique genes and pathways that may have potential importance in ovarian pathogenesis and biomarker development.

KW - E2F

KW - Gene expression

KW - p53

KW - Serous borderline tumor

KW - Stage I serous carcinoma

UR - http://www.scopus.com/inward/record.url?scp=66049138503&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=66049138503&partnerID=8YFLogxK

U2 - 10.1016/j.ygyno.2009.04.002

DO - 10.1016/j.ygyno.2009.04.002

M3 - Article

C2 - 19410283

AN - SCOPUS:66049138503

VL - 114

SP - 3

EP - 11

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 1

ER -